January 10, 2018 – Braeburn today announced that the Company has completed a $110 million mezzanine round of financing led by Wellington Management Company. Other new investors participating in the financing include Avista Capital Partners, Deerfield Management, New Leaf Venture Partners, RA Capital Management and Rock Springs Capital.

Braeburn Pharmaceuticals, Inc. provides health care services. The Company aims to acquire one and more businesses and assets, via a merger, capital stock

Braeburn Pharmaceuticals has raised $110 m in total funding. View Braeburn Pharmaceuticals stock / share price, financials, funding rounds, investors and more at Craft. Opioid addiction, also known as opioid use disorder (OUD), is a medical condition requiring medical treatment. Together with counseling and support, Braeburn’s next generation medicines are developed with an aim to support patients with OUD as they focus on the reintegration of their lives and communities.

A high-level overview of Braeburn Pharmaceuticals (BBRX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Braeburn Pharmaceuticals, Inc. Common Stock: ISIN-Sektor-Bransch-Kortnamn: BBRX: Introduktionsdatum-Belåningsgrad-Säkerhetskrav- BRAEBURN PHARMACEUTICALS INC : Stock quote, stock chart, quotes, analysis, advice, financials and news for share BRAEBURN PHARMACEUTICALS INC | Nasdaq: BBRX | Nasdaq BBRX Braeburn Pharmaceuticals — Stock Price and Discussion | Stocktwits. Braeburn Pharmaceuticals NASDAQ Updated Dec 31, 1969 4:00 PM. BBRX. Braeburn Pharmaceuticals stock price, funding rounds, valuation and financials. Braeburn Pharmaceuticals has raised $110 m in total funding.

Braeburn Pharmaceuticals Inc filed with U.S. regulators on Friday to raise up to $150 million in an initial public offering, seven months after its implant to treat opioid addiction was approved

Together with counseling and support, Braeburn’s next generation medicines are developed with an aim to support patients with OUD as they focus on the reintegration of their lives and communities. January 10, 2018 – Braeburn today announced that the Company has completed a $110 million mezzanine round of financing led by Wellington Management Company. Other new investors participating in the financing include Avista Capital Partners, Deerfield Management, New Leaf Venture Partners, RA Capital Management and Rock Springs Capital. Braeburn Pharmaceuticals has raised $110 m in total funding.

2021-04-10 · Braeburn Pharmaceuticals, Inc. (BBRX) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.

BBRX. Braeburn Pharmaceuticals Inc. NA. BBSI. Barrett Business Services Inc. Common Stock.

Braeburn is committed to the fight against opioid use disorder. Opioid addiction, also known as opioid use disorder (OUD), is a medical condition requiring medical treatment. Together with counseling and support, Braeburn’s next generation medicines are developed with an aim to support patients with OUD as they focus on the reintegration of their lives and communities. January 10, 2018 – Braeburn today announced that the Company has completed a $110 million mezzanine round of financing led by Wellington Management Company.
Fotbollsagenter

Jane Henney 9 Apr 2019 Which brings us back to the dispute between pharmaceutical companies Braeburn and Indivior.

2021-04-03 · Braeburn Pharmaceuticals, Inc. (BBRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
Mc körkort online

account svenska
sql kurs online gratis
alternativ till hypotekspension
utbildningsinstitutet lund
polismyndigheten rättsavdelningen kiruna kontakt
georg klein uni siegen

Company profile page for Braeburn Inc including stock price, company news, press releases, executives, board members, and contact information

Hos Nordnet kan du handla från 0 kr i courtage.